-+ 0.00%
-+ 0.00%
-+ 0.00%

Maverix Medical Announces FDA 510(k) Clearance for the Narwhal™ Cryo System

Barchart·08/20/2026 07:05:00
Listen to the news

Console-free, single-use cryoprobe brings cryobiopsy to the bronchoscopy suite without dedicated capital equipment

MENLO PARK, Calif., Aug. 20, 2026 /PRNewswire/ -- Maverix Medical, a company focused on revolutionizing the diagnosis and treatment of lung cancer, today announced that the U.S. Food and Drug Administration granted 510(k) clearance on June 30, 2026 for the Maverix Narwhal™ Cryo System, a single-use flexible cryoprobe that requires no console.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.